Nymox Pharmaceutical Corporation NYMX

Annual report 2024
added 03-07-2026

Nymox Pharmaceutical Corporation DIO Ratio 2011-2026 | NYMX

Annual DIO Ratio Nymox Pharmaceutical Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	5.46	85.7	186	29.8	61.1	29.7

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
186	5.46	66.2

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Aptorum Group Limited APM	4.89	$ 0.79	-1.15 %	$ 4.31 M	China
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Grifols, S.A. GRFS	0.000171	$ 7.81	-2.01 %	$ 6.83 B	Spain
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	BioCardia BCDA	4.08	$ 1.26	-0.79 %	$ 26.7 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Anika Therapeutics ANIK	247	$ 14.2	-0.7 %	$ 208 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	AVEO Pharmaceuticals AVEO	63.8	-	-	$ 521 M	USA
	Aytu BioScience AYTU	209	$ 2.54	-5.22 %	$ 16 M	USA